Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Venetoclax and Cytarabine in AML Transformed from Myelofibrosis

John McKay, DO, Matthew Gayhart, MD, Taha Al-Juhaishi, MD, Victor Yazbeck, MD, Edward B. Perkins, MD PhD

Blood (2019) 134 (Supplement_1): 5140.

https://doi.org/10.1182/blood-2019-129429

Published: 2019

Journal Articles

Hypercalcemia- Leukocytosis Syndrome: A Rare Ominous Indicator in Lung Cancer

Taylor Hanson, Ravi Patel, DO, Nitasa Sahu, MD, Zain Ayaz, MD, Julie Caler, Pharm.D, Kirk Jones, Pharm.D, Rohit Jain, MBBS

Blood (2018) 132 (Supplement 1): 4966.

https://doi.org/10.1182/blood-2018-99-112705

Published: 2018

Journal Articles

Inadequate Illness Understanding and Suboptimal Levels of Advance Care Planning in Patients with Aggressive Lymphoma

Kelly Marie Trevino, PhD, Peter Martin, FRCPC, MD MS, Sarah C. Rutherford, Chrystal Marte, Daniel Jie Ouyang, Holly Prigerson, PhD, John P. Leonard, MD

Blood (2018) 132 (Supplement 1): 4842.

https://doi.org/10.1182/blood-2018-99-112102

Published: 2018

Journal Articles

Weight Gain during Induction Therapy of Acute Promyelocytic Leukemia Patients: A Preventable Problem

Vamsi Kota, MBBS, Prachi Kharkhanis, Catherine R. Caprara, MSN, NP, Sheldon Bolds, Stephanie Debragga, Kathryn Sarah Simon, PA-C, Martha L. Arellano, MD, Anand Jillella, MD

Blood (2017) 130 (Supplement 1): 5017.

https://doi.org/10.1182/blood.V130.Suppl_1.5017.5017

Published: 2017

Journal Articles

Impact of Molecular Clonality on Survival in Acute Myeloid Leukemia

Wade L Schulz, MD PhD, Thomas JS Durant, MD, Henry Rinder, MD, Christopher A Tormey, MD, Richard Torres, MD, Brian R Smith, MD, Karl M Hager, PhD, John G Howe, PhD, Alexa J Siddon, MD

Blood (2015) 126 (23): 1385.

https://doi.org/10.1182/blood.V126.23.1385.1385

Published: 2015

Journal Articles

Oncology Providers Ability to Prognosticate Patient Outcomes: An Analysis of the Survey on Provider Assessment of Risk (SPAR) Study

Sarah A. Buckley, MD, Megan Othus, PhD, Paul C. Hendrie, MD PhD, Elihu H. Estey, MD, Roland B. Walter, MD PhD MS

Blood (2015) 126 (23): 5635.

https://doi.org/10.1182/blood.V126.23.5635.5635

Published: 2015

Journal Articles

A Single Center Retrospective Analysis of Outcomes Following the Use of 4-Factor Prothrombin Complex Concentrate for Warfarin Reversal in Real-Life Settings

Ranjit Joseph, MD, Amanda Strickland, James Burner, MD, Sean Yates, MD, William Tharpe, PharmD, Ravindra Sarode, MD

Blood (2014) 124 (21): 1561.

https://doi.org/10.1182/blood.V124.21.1561.1561

Published: 2014

Journal Articles

Novel Description of Prospective Diagnosis of Congenital Acute Leukemia On Initial Processing of Banked Umbilical Cord Blood and Potential Implications for Testing Laboratories

Garth Aasen, MD, Micah Will, MD, Xiayuan Liang, MD, Jeffrey Schowinsky, MD

Blood (2012) 120 (21): 4129.

https://doi.org/10.1182/blood.V120.21.4129.4129

Published: 2012

Journal Articles

An Uncommon Presentation of Adult Hemophagocytic Lymphohistiocytosis with Severe Pulmonary Hypertension

Lauren Marie Gerard, MD, Katharine He Xing, MD, Christine M Cserti-Gazdewich, MD, FRCPC, FASCP

Blood (2011) 118 (21): 4734.

https://doi.org/10.1182/blood.V118.21.4734.4734

Published: 2011

Journal Articles

Phase II Trial of Combination of Bortezomib and Rituximab in Relapsed and/or Refractory Waldenstrom Macroglobulinemia

Irene M. Ghobrial, M.D., Jeffrey Matous, MD, Swaminathan Padmanabhan, MD, Ashraf Badros, MD, Robert Schlossman, MD, Stacey Chuma, RN, Renee Leduc1, Marybeth Nelson, PA, Kelly O’Connor, Amy Sam, Brianna Harris, Jacob Soumerai, Diane Warren, Ann Birner, Nikhil Munshi, MD, Steven P. Treon, MD, PhD, Kenneth C. Anderson, MD, Paul Richardson, MD

Blood (2008) 112 (11): 832.

https://doi.org/10.1182/blood.V112.11.832.832

Published: 2008

Journal Articles

Bivalirudin in the Treatment of Patients with or at High-Risk for Heparin-Induced Thrombocytopenia.

James N. Frame, Todd Derreberry, Elaine A. Davis, Ying Wang

Blood (2006) 108 (11): 4120.

https://doi.org/10.1182/blood.V108.11.4120.4120

Published: 2006

Journal Articles

A Case of Fulminant Myelodysplastic Syndrome Versus Acute Erythroleukemia Variant.

Fermina M. Mazzella, MD

Blood (2005) 106 (11): 4900.

https://doi.org/10.1182/blood.V106.11.4900.4900

Published: 2005

NARROW

Venetoclax and Cytarabine in AML Transformed from Myelofibrosis

Hypercalcemia- Leukocytosis Syndrome: A Rare Ominous Indicator in Lung Cancer

Inadequate Illness Understanding and Suboptimal Levels of Advance Care Planning in Patients with Aggressive Lymphoma

Weight Gain during Induction Therapy of Acute Promyelocytic Leukemia Patients: A Preventable Problem

Impact of Molecular Clonality on Survival in Acute Myeloid Leukemia

Oncology Providers Ability to Prognosticate Patient Outcomes: An Analysis of the Survey on Provider Assessment of Risk (SPAR) Study

A Single Center Retrospective Analysis of Outcomes Following the Use of 4-Factor Prothrombin Complex Concentrate for Warfarin Reversal in Real-Life Settings

Novel Description of Prospective Diagnosis of Congenital Acute Leukemia On Initial Processing of Banked Umbilical Cord Blood and Potential Implications for Testing Laboratories

An Uncommon Presentation of Adult Hemophagocytic Lymphohistiocytosis with Severe Pulmonary Hypertension

Phase II Trial of Combination of Bortezomib and Rituximab in Relapsed and/or Refractory Waldenstrom Macroglobulinemia

Bivalirudin in the Treatment of Patients with or at High-Risk for Heparin-Induced Thrombocytopenia.

A Case of Fulminant Myelodysplastic Syndrome Versus Acute Erythroleukemia Variant.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only